ELAB PMGC Holdings Inc.

NEUTRAL Impact: 4/10 PRESS-RELEASE
Horizon months Filed Jun 8, 2026 Processed 6d 22h ago Wire GlobeNewswire
Press release: contract

Price Chart

Loading chart...

Executive Summary

PMGC Holdings subsidiary NorthStrive Defense Tech signed a binding term sheet for an exclusive, worldwide, sublicensable license to a U.S. patent covering autonomous buoyancy-assisted drone payload transport across air and water, plus a 12-month sponsored research agreement. The deal is early-stage with no disclosed financial terms, no revenue, and no near-term commercial product — a speculative technology licensing event for a micro-cap company.

Actionable Insight

This is a speculative, early-stage licensing deal with no hard financials. The stock has a history of severe negative drift after filings (avg T+20 -30.30%). Traders should avoid directional bets until concrete milestones or contract awards materialize — the technology is years from commercialization.

Key Facts

  • Binding term sheet for exclusive, worldwide, sublicensable license to U.S. Patent No. 12,291,334 in aerospace and defense field.
  • Sponsored research agreement: 12-month term (June 2026 to June 2027), milestone-based funding, no dollar amounts disclosed.
  • No revenue, no purchase orders, no contract awards — technology is at prototype stage.
  • PMGC Holdings (ELAB) has a $7M market cap; historical reports on ELAB show an average T+20 loss of -30.30% and a 17% win rate.
  • Cross-filing actuarial verdicts flag amplifiers for press-8k-context + press-offering-context, but no offering or 8-K context is present in this filing.

Financial Impact

No financial terms disclosed — license fee, royalties, or research funding amounts are not stated.

Risk Factors

  • No disclosed financial terms — license fee, royalties, or research costs unknown.
  • Technology is at prototype stage; no guarantee of successful development or commercial adoption.
  • Micro-cap ($7M) with poor historical filing performance — high risk of continued downside drift.
  • Forward-looking statements are aspirational; no binding customer commitments or revenue.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3307996
19 reports for ELAB
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+20▲ +42.86%Apr 20, 2026
Filters
Rows
Reports for ELAB — sortable, filterable
Type Now
Jun 8, 2026
6d ago
Press Release
NEUTRAL ★ 4/10
$1.52 awaiting T+5awaiting T+5$1.47 (−3.29%)
Jun 5, 2026
9d ago
8-K
NEUTRAL ★ 4/10
$1.55 awaiting T+5awaiting T+5$1.47 (−5.16%)
Jun 1, 2026
13d ago
Press Release
NEUTRAL ★ 4/10
$1.77 $1.54▼ −12.99%▼ −10.24%$1.47 (−16.95%)
May 13, 2026
4w ago
8-K
MIXED ★ 7/10
$1.98 $1.75▼ −11.62%▼ −10.46%$1.47 (−25.76%)
May 13, 2026
4w ago
Press Release
NEUTRAL ★ 5/10
$1.98 $1.75▼ −11.62%▼ −10.46%$1.47 (−25.76%)
Apr 23, 2026
7w ago
8-K
MIXED ★ 6/10
$2.94 $2.53▼ −13.95%▼ −15.42%$1.47 (−50.00%)
Apr 23, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$2.94 $2.53▼ −13.95%▼ −15.42%$1.47 (−50.00%)
Apr 21, 2026
7w ago
8-K
BULLISH ★ 6/10
$3.29 $2.54▼ −22.80%▼ −23.88%$1.47 (−55.32%)
Apr 20, 2026
7w ago
424B5
BEARISH ★ 6/10
$3.29 $2.54▲ +22.80%▲ +23.88%$1.47 (+55.32%)
Apr 17, 2026
8w ago
8-K
MIXED ★ 6/10
$3.28 $2.49▼ −24.09%▼ −24.64%$1.47 (−55.18%)
Showing 10 of 19

US Market Status

Market Closed — Opens in 3h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access